AEMD Key Statistics, Chart & Performance
The current stock price of AEMD is 2.66 USD. In the past month the price decreased by -30%. In the past year, price decreased by -95.52%.
AEMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.67 | 214.02B | ||
| ISRG | INTUITIVE SURGICAL INC | 64.75 | 197.63B | ||
| BSX | BOSTON SCIENTIFIC CORP | 31.61 | 138.23B | ||
| SYK | STRYKER CORP | 26.85 | 135.25B | ||
| IDXX | IDEXX LABORATORIES INC | 56.44 | 56.83B | ||
| BDX | BECTON DICKINSON AND CO | 13.89 | 57.16B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.34 | 48.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.63 | 38.96B | ||
| RMD | RESMED INC | 25.71 | 37.15B | ||
| DXCM | DEXCOM INC | 37.58 | 27.26B | ||
| PODD | INSULET CORP | 61.12 | 19.65B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.81 | 17.33B |
Related stock screener links
About AEMD
Company Profile
Aethlon Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in San Diego, California and currently employs 9 full-time employees. Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Company Info
AETHLON MEDICAL INC
11555 Sorrento Valley Road, Suite 203
San Diego CALIFORNIA 92123 US
CEO: Charles J. Fisher Jr
Employees: 9
Phone: 16199410360
AETHLON MEDICAL INC / AEMD FAQ
Can you describe the business of AETHLON MEDICAL INC?
Aethlon Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in San Diego, California and currently employs 9 full-time employees. Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Can you provide the latest stock price for AETHLON MEDICAL INC?
The current stock price of AEMD is 2.66 USD. The price increased by 11.76% in the last trading session.
What is the dividend status of AETHLON MEDICAL INC?
AEMD does not pay a dividend.
What is the ChartMill rating of AETHLON MEDICAL INC stock?
AEMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the GICS sector and industry of AEMD stock?
AETHLON MEDICAL INC (AEMD) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the market capitalization of AEMD stock?
AETHLON MEDICAL INC (AEMD) has a market capitalization of 2.02M USD. This makes AEMD a Nano Cap stock.
AEMD Technical Analysis
AEMD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AEMD. The financial health of AEMD is average, but there are quite some concerns on its profitability.
AEMD Financial Highlights
Over the last trailing twelve months AEMD reported a non-GAAP Earnings per Share(EPS) of -102.34. The EPS increased by 54.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -153.74% | ||
| ROE | -195.94% | ||
| Debt/Equity | 0 |
AEMD Forecast & Estimates
7 analysts have analysed AEMD and the average price target is 12.62 USD. This implies a price increase of 374.53% is expected in the next year compared to the current price of 2.66.